Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Leading Board-Certified Plastic Surgeon Dr. David W. Allison Moves to New Princeton Location on Bunn Drive
Healthcare & PharmaceuticalCompany Update

Leading Board-Certified Plastic Surgeon Dr. David W. Allison Moves to New Princeton Location on Bunn Drive

February 10, 2026 12:00 PM

Board-certified plastic surgeon David W. Allison, MD has relocated his practice to Princeton, New Jersey, now seeing patients at 256 Bunn Drive, Suite A1, as part of the Becker Plastic Surgery network. The move reflects a continued commitment to providing comprehensive cosmetic and reconstructive plastic surgery care in a convenient Central New Jersey setting. Dr. Allison brings more than 23 years of surgical experience and has performed over...

Read more
CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
Healthcare & PharmaceuticalRegulatory

CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity

February 10, 2026 11:45 AM

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the "Company")(LSE:HEMO) is pleased to announce that it has raised £2,500,000 from a consortium of private investors through a direct subscription for 333,333 new ordinary shares in the Company at a price of £7.50 per share. The new investors will also receive a three year warrant to subscribe on a one-for-one basis for ordinary shares in the Company at £9 per share. Some of these...

Read more
MDCE Turns $1M Asset Portfolio Into Strategic Capital for AI Development (OTC PINK:MDCE)
Healthcare & PharmaceuticalCompany Update

MDCE Turns $1M Asset Portfolio Into Strategic Capital for AI Development (OTC PINK:MDCE)

February 10, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced it is executing a non-dilutive funding strategy supported by tangible, high-value assets held by its wholly owned subsidiary, Infinite Auctions, which currently maintains an estimated market value approaching $1 million in sports cards and elite game-worn memorabilia. This is exciting news with the pending release of the company's first AI based mobile application. As part of this...

Read more
TRNR Files Lawsuits Against Sportstech and Ali Ahmad and Announces March 11, 2026 Public Auction of All Shares of Sportstech
Healthcare & PharmaceuticalCompany Update

TRNR Files Lawsuits Against Sportstech and Ali Ahmad and Announces March 11, 2026 Public Auction of All Shares of Sportstech

February 10, 2026 9:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) (the "Company") today announced that it has filed two distinct lawsuits in connection with the previously disclosed defaulted loan to Sportstech Brands Holding GmbH ("Sportstech"), and the corresponding personal guarantee by Ali Ahmad. The Company further announced that a public auction of 100% of the shares in Sportstech pledged to Interactive Strength will be conducted on March 11, 2026, at 11:00 a.m....

Read more
Change of Date for Publication of the Interim Report January-March 2026
Healthcare & PharmaceuticalCompany Update

Change of Date for Publication of the Interim Report January-March 2026

February 10, 2026 9:15 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO Perfusion AB (publ) has decided to postpone the publication of its interim report for the period January-March 2026. The interim report will be published on Friday, 24 April 2026, instead of the previously communicated date of Wednesday, 22 April 2026. The change is due to the fact that the previously announced reporting date coincides with the presentation of XVIVO's U.S. heart...

Read more
NCQA Kicks Off Inaugural Learning Collaborative to Measure Patient Engagement
Healthcare & PharmaceuticalCompany Update

NCQA Kicks Off Inaugural Learning Collaborative to Measure Patient Engagement

February 10, 2026 9:05 AM

The National Committee for Quality Assurance (NCQA) officially launched its Measuring Patient Engagement Learning Collaborative as part of a series designed to explore how healthcare organizations should assess, manage and deliver digitally-enabled interventions to support effective condition management and well-being. NCQA is convening 13 organizations from across the health ecosystem, representing health plans, vendors, clinicians and...

Read more
Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Healthcare & PharmaceuticalCompany Update

Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides

February 10, 2026 8:30 AM

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has filed an application for "Orphan Drug Designation" (ODD) for NV-387 as a Treatment for Measles with the US FDA Office of Orphan Products Development (OOPD). If approved,...

Read more
Best Mushroom Extract Supplements in 2026: How Formulations Are Evaluated
Healthcare & PharmaceuticalAdvertorial

Best Mushroom Extract Supplements in 2026: How Formulations Are Evaluated

February 10, 2026 8:20 AM

What Mushroom Extract Supplements Are and Why People Use Them in 2026 Mushroom extract supplements have firmly moved from a niche wellness trend into a mainstream category by 2026. What was once associated mostly with alternative nutrition or experimental routines is now part of everyday supplement stacks for many people. The reason is simple: mushroom extracts are no longer marketed as exotic solutions, but as practical, routine-friendly...

Read more
DirectTrust(R) Reports Record High Exchange Activity in 2025, With Nearly 1.9 Billion Direct Exchange Transactions
Healthcare & PharmaceuticalCompany Update

DirectTrust(R) Reports Record High Exchange Activity in 2025, With Nearly 1.9 Billion Direct Exchange Transactions

February 10, 2026 8:00 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare technology and data exchange through standards, accreditation, and other services, today announced full-year 2025 metrics from its accredited Health Information Service Provider (HISP) members, highlighting record-high Direct exchange activity in 2025 and continued growth in the use of the DirectTrust national network for secure, interoperable...

Read more
Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Healthcare & PharmaceuticalRegulatory

Aspire Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

February 10, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced that it has received formal notice from the Listings Qualifications staff of The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share. The Company...

Read more
How Consumers Identify the Best Lion's Mane Supplements in 2026: Market Research
Healthcare & PharmaceuticalAdvertorial

How Consumers Identify the Best Lion's Mane Supplements in 2026: Market Research

February 10, 2026 7:15 AM

What Is Lion's Mane and Why People Use It in 2026 Lion's Mane is one of those supplements that almost everyone has heard about by 2026, but not everyone truly understands. Many people buy it because they saw it mentioned in a podcast, a forum discussion, or a productivity stack - yet the real value of Lion's Mane only becomes clear once you understand what it is, how it works, and how to use it correctly. At its core, Lion's Mane is a functional...

Read more
Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico
Healthcare & PharmaceuticalCompany Update

Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico

February 10, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced it has signed a Memorandum of Understanding (MoU) for a long-term strategic agreement with the Mexican Government, Laboratorios de Biológicos y Reactivos de Mexico (BIRMEX), and Laboratorios Liomont (Liomont), to enhance Mexico's health sovereignty and mRNA manufacturing resilience. The five-year agreement will include the supply of Moderna's respiratory vaccine portfolio, as well as technology...

Read more
Who Does Cheapest Breast Augmentation in Las Vegas?
Healthcare & PharmaceuticalAdvertorial

Who Does Cheapest Breast Augmentation in Las Vegas?

February 10, 2026 6:00 AM

As cosmetic surgery costs continue to rise nationwide, some Las Vegas patients are increasingly searching for lower‑cost options for common procedures such as breast augmentation. Among clinics advertising publicly available pricing, Las Vegas Body Sculpting, led by Dr. Mustafa Ahmed lists one of the lowest starting prices in the region: $4,995 for breast augmentation with saline implants. Reported Pricing and Market Context The price point...

Read more
Monthly Update January - Broad Momentum and the Launch of a New Platform
Healthcare & PharmaceuticalCompany Update

Monthly Update January - Broad Momentum and the Launch of a New Platform

February 10, 2026 3:15 AM

iZafe Group (STO:IZAFE-B) - 2026 has kicked off with continued high pace and several important developments in both the Swedish and international markets. With many parallel initiatives and rollouts underway, we are strengthening our presence, deepening partnerships, and continuing to build for broader deployment of Dosell, with an even greater focus on scalability and flexibility. We enter the year with a strong pipeline, an increasing number...

Read more
Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
Healthcare & PharmaceuticalRegulatory

Hemogenyx Pharmaceuticals PLC Announces Issue of Equity

February 10, 2026 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised £2,500,000 from a consortium of private investors through a direct subscription for 313,333 new ordinary shares in the Company at a price of £7.50 per share. The new investors will also receive a three year warrant to subscribe on a one-for-one basis for ordinary shares in the Company at £9 per share. Some of these investors taken part in earlier share...

Read more
Best Turmeric and Curcumin Supplement in 2026: Buyer’s Guide and Review
Healthcare & PharmaceuticalAdvertorial

Best Turmeric and Curcumin Supplement in 2026: Buyer’s Guide and Review

February 9, 2026 2:45 PM

What Is a Turmeric & Curcumin Supplement and Why It Matters in 2026 Turmeric supplements have become one of the most widely researched and discussed botanical products in the wellness category, and in 2026 they remain a core part of many daily routines focused on joint comfort, antioxidant support, and overall balance. While turmeric as a spice has been used for centuries, modern supplements are designed to deliver standardized curcumin-the...

Read more
Amazon Showcases Addison Care(R) at National Rural Health Leadership Conference, Showcasing the First Fully Orchestrated AI-Driven Care Infrastructure Built for Rural America
Healthcare & PharmaceuticalConferences

Amazon Showcases Addison Care(R) at National Rural Health Leadership Conference, Showcasing the First Fully Orchestrated AI-Driven Care Infrastructure Built for Rural America

February 9, 2026 12:00 PM

At the 2026 AHA Rural Health Care Leadership Conference, Amazon is showcasing Addison Care®, the nation's most comprehensive AI-driven virtual care and TeleCare orchestration platform, purpose-built to address the most urgent challenges facing rural healthcare systems today. Presented in collaboration with Amazon Web Services, Addison Care is being introduced to rural health leaders as a deployment-ready solution that extends care from the...

Read more
MDCE's Infinite Auctions Unveils
Healthcare & PharmaceuticalCompany Update

MDCE's Infinite Auctions Unveils "The Legends Art Auction" - A Nearly $3 Million Showcase of Stan Lee-Signed Masterpieces and Viral Sports Art Phenomena

February 9, 2026 9:30 AM

Infinite Auctions (www.infiniteauctions.com), a subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), today announced the official preview launch of "The Legends Art Auction," a premier fine art event showcasing iconic, rare, and culturally significant works with a combined appraised value approaching $3 million. The auction goes live on February 13 at Noon, giving collectors, investors, and art enthusiasts an exclusive first look at a...

Read more
North York Sleep & Diagnostic Centre Urges Greater Awareness of Sleep Health
Healthcare & PharmaceuticalCompany Update

North York Sleep & Diagnostic Centre Urges Greater Awareness of Sleep Health

February 9, 2026 8:50 AM

North York Sleep & Diagnostic Centre is calling for greater public awareness of sleep health, emphasizing the importance of early diagnosis and medically supervised care for individuals experiencing persistent sleep-related concerns. With more than 15 years of clinical experience, the Centre continues to see the significant impact untreated sleep disorders can have on daily functioning and long-term well-being. Sleep-related issues are...

Read more
NFL Alumni Health Partners with Wellgistics Health to Deploy Technology to Improve Health Outcomes for Former NFL Players and Rural Communities
Healthcare & PharmaceuticalPartnerships

NFL Alumni Health Partners with Wellgistics Health to Deploy Technology to Improve Health Outcomes for Former NFL Players and Rural Communities

February 9, 2026 8:30 AM

Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (‘AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that it has entered into an agreement with NFL Alumni Health to establish healthcare and wellness programs that expand access to healthcare and wellness services,...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?